Skip to main navigation Skip to search Skip to main content

Progesterone receptor modulates ERα action in breast cancer

  • Hisham Mohammed
  • , I. Alasdair Russell
  • , Rory Stark
  • , Oscar M. Rueda
  • , Theresa E. Hickey
  • , Gerard A. Tarulli
  • , Aurelien A.A. Serandour
  • , Stephen N. Birrell
  • , Alejandra Bruna
  • , Amel Saadi
  • , Suraj Menon
  • , James Hadfield
  • , Michelle Pugh
  • , Ganesh V. Raj
  • , Gordon D. Brown
  • , Clive D'Santos
  • , Jessica L.L. Robinson
  • , Grace Silva
  • , Rosalind Launchbury
  • , Charles M. Perou
  • John Stingl, Carlos Caldas, Wayne D. Tilley*, Jason S. Carroll
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

600 Scopus citations

Abstract

Progesterone receptor (PR) expression is used as a biomarker of oestrogen receptor-α (ERα) function and breast cancer prognosis. Here we show that PR is not merely an ERα-induced gene target, but is also an ERα-associated protein that modulates its behaviour. In the presence of agonist ligands, PR associates with ERα to direct ERα chromatin binding events within breast cancer cells, resulting in a unique gene expression programme that is associated with good clinical outcome. Progesterone inhibited oestrogen-mediated growth of ERα+ cell line xenografts and primary ERα+ breast tumour explants, and had increased anti-proliferative effects when coupled with an ERα antagonist. Copy number loss of PGR, the gene coding for PR, is a common feature in ERα+ breast cancers, explaining lower PR levels in a subset of cases. Our findings indicate that PR functions as a molecular rheostat to control ERα chromatin binding and transcriptional activity, which has important implications for prognosis and therapeutic interventions.

Original languageEnglish
Pages (from-to)313-317
Number of pages5
JournalNature
Volume523
Issue number7560
DOIs
StatePublished - 16 Jul 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2015 Macmillan Publishers Limited. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Progesterone receptor modulates ERα action in breast cancer'. Together they form a unique fingerprint.

Cite this